Prof. Dr. Rainer Fietkau

Medizinische Fakultät Lehrstuhl für Strahlentherapie

Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors (2016) Derer A, Frey B, Fietkau R, Gaipl U Journal article Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial (2016) Herrlinger U, Schaefer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, et al. Journal article Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo (2016) Werthmöller N, Frey B, Rueckert M, Lotter M, Fietkau R, Gaipl U Journal article Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin (2016) Muth C, Ruebner Y, Semrau S, Rühle PF, Frey B, Strnad A, Buslei R, et al. Journal article Erratum to: Primary glioblastoma multiforme tumors and recurrence: comparative analysis of the danger signals HMGB1, HSP70, and calreticulin (2016) Muth C, Rubner Y, Semrau S, Rühle PF, Frey B, Strnad A, Buslei R, et al. Journal article, Erratum Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy (2016) Bertz S, Wach S, Taubert H, Merten R, Krause FS, Schick S, Ott OJ, et al. Journal article Recurrent glioblastoma: who receives tumor specific treatment and how often? (2016) Steffens R, Semrau S, Lahmer G, Putz F, Lettmaier S, Eyüpoglu IY, Buchfelder M, Fietkau R Journal article Effective local control of advanced soft tissue sarcoma with neoadjuvant chemoradiotherapy and surgery: A single institutional experience (2016) Stubbe F, Agaimy A, Ott O, Lettmaier S, Vassos N, Croner R, Hohenberger W, et al. Journal article Neoadjuvant Radiochemotherapy Followed by Curative Resection in Patients with Advanced Non-Small Cell Lung Cancer in Stage IIIA/IIIB: Prognostic Factors and Results (2016) Schreiner W, Dudek W, Lettmaier S, Gavrychenkova S, Rieker R, Fietkau R, Sirbu H Journal article Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment (2016) Goerig N, Semrau S, Frey B, Korn K, Fleckenstein B, Überla K, Dörfler A, et al. Journal article